<DOC>
	<DOCNO>NCT02406157</DOCNO>
	<brief_summary>This randomize , parallel control , clinical-trial aim evaluate therapeutic efficacy safety 577nm micropulse laser photocoagulation diabetic macular edema compare 532 subthreshold laser photocoagulation .</brief_summary>
	<brief_title>577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation Diabetic Macular Edema</brief_title>
	<detailed_description>1 . To evaluate efficacy 577nm micropulse laser photocoagulation grid/focal treatment diabetic macular edema . 2 . To investigate influence 577nm micropulse laser photocoagulation structure function macula compare 532nm subthreshold laser photocoagulation .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Aged ＞18 year Patients diabetes mellitus type 2 Diagnosed diabetic retinopathy Clinical Significant Macular Edema Central retinal thickness ( CRT ) 250μm measured optical coherence tomography ( OCT ) ETDRS visual acuity ＞19 letter ( Snellen equivalent 20/400 good ) No macular laser coagulation surgery medicine therapy macular edema within last 6 month Blood glucose control steadily ( HbA1c≤10 % ) Taking part clinical trial within 3 month Planning panretinal photocoagulation ( PRP ) within 3 month Performed cataract surgery last 3 month Accompanied retinal vascular disease lead macular edema , example branch retinal vein occlusion ( BRVO ) , central retinal vein occlusion ( CRVO ) Accompanied severe opacity refractive medium maybe impact therapy observation Accompanied nystagmus Accompanied history maybe interfere result increase risk patient</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>diabetic macular edema</keyword>
	<keyword>micropulse</keyword>
	<keyword>laser</keyword>
	<keyword>subthreshold</keyword>
</DOC>